Howard Liang, CFO & Chief Strategy Officer at BeiGene, Ltd. (BGNE), sold 25,000 shares at $303.24 ($7.5M) on 2020-10-05, disclosed to the SEC on 2020-10-07.
Open-market sale of $7.5M BGNE by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $293.26 | 817 | $240K | 3.2% |
| 2 | $293.26 | 817 | $240K | 3.2% |
| 3 | $294.92 | 1,415 | $417K | 5.6% |
| 4 | $294.92 | 1,415 | $417K | 5.6% |
| 5 | $295.73 | 568 | $168K | 2.2% |
| 6 | $295.73 | 568 |
| $168K |
| 2.2% |
| 7 | $296.47 | 500 | $148K | 2.0% |
| 8 | $297.98 | 1,200 | $358K | 4.8% |
| 9 | $298.97 | 1,000 | $299K | 4.0% |
| 10 | $300.08 | 2,001 | $600K | 8.0% |
| 11 | $300.08 | 2,001 | $600K | 8.0% |
| 12 | $300.88 | 1,499 | $451K | 6.0% |
| 13 | $300.88 | 1,499 | $451K | 6.0% |
| 14 | $302.11 | 2,831 | $855K | 11.4% |
| 15 | $302.11 | 2,831 | $855K | 11.4% |
| 16 | $303.24 | 1,869 | $567K | 7.6% |
| 17 | $303.24 | 1,869 | $567K | 7.6% |
| 18 | $304.15 | 300 | $91K | 1.2% |
| Total | $299.71 avg | 25,000 | $7.5M | 100% |
| Filing → |
| BGNE | SELL | 2021-06-09 | $460K | — | Filing → |
| BGNE | SELL | 2021-01-19 | $9.6M | — | Filing → |
| BGNE | SELL | 2020-12-16 | $39.2M | — | Filing → |